GRM1 and amyotrophic lateral sclerosis: Both Groups I and II mGluRs (mGluR1/5; mGluR2/3) are overexpressed in the astrocytes of ALS animal models and patients [199,329,330,331], thus being considered good pharmacological targets in ALS [332].